Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Behnke, B.
Right arrow Articles by Muller-Wiefel, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Behnke, B.
Right arrow Articles by Muller-Wiefel, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 13, Issue 3 662-667, Copyright © 1998 by Oxford University Press

ORIGINAL ARTICLES

Bone alkaline phosphatase in children with chronic renal failure

B Behnke, M Kemper, H Kruse and D Muller-Wiefel
Departments of Pediatrics and Nephrology and Osteology, Universitats-Kinderklinik, Hamburg-Eppendorf, D-20246 Hamburg, Germany; Corresponding author

Background: With the introduction of a new immunoradiometric assay based on two monoclonal antibodies (Tandem®-Ostase, Hybritech) the determination of bone alkaline phosphatase (BAP) to evaluate bone metabolism in chronic renal failure has become easier and more valid. Subjects and methods: Using this test we investigated BAP in a total of 90 paediatric patients, 42 (9.2±5.5 years) with chronic renal failure on conservative treatment, 22 (9.5±5.4 years) under chronic dialysis, and 26 (16.2±5.9 years) after renal transplantation, compared to 203 controls (10.1±5.7 years). Results: The physiological age dependency found in controls including two peaks during infancy and puberty was distinctly disturbed in chronic renal failure. However, in patients BAP significantly correlated with height velocity rather reflecting the last 6 (r=0.56 P<0.001) than the last 12 months. Although BAP correlated well with total alkaline phosphatase (TAP; r=0.95 P<0.001), a significant correlation with the serum level of the intact parathyroid hormone could only be detected for BAP (r=0.45 P<0.001) but not for TAP (R=0.19 N.S.) Furthermore, BAP positively correlated with trabecular (n=40; r=0.40 P<0.05) and inversely with cortical bone density (n=19; r=-0.58 P<0.01) but no relationship was found with conventional X-ray. Conclusion: BAP determined by the new radioimmunoassay seems to represent an additional diagnostic tool to assess growth and bone turnover in paediatric patients with chronic renal failure that is complementary to the information provided by X-ray and total alkaline phosphatase. Key words: bone alkaline phosphatase; children; chronic renal failure
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
B. Behnke, M. J. Kemper, H.-P. Kruse, and D. E. Muller-Wiefel
Bone mineral density in children with primary hyperoxaluria type I
Nephrol. Dial. Transplant., November 1, 2001; 16(11): 2236 - 2239.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.